Abstract：Objective To investigate the clinical effect of Atorvastatin in the treatment of subacute subdural hematoma.Methods A total of 50 patients with subacute subdural hematoma in our hospital from March 2017 to March 2019 were divided into the observation group and the control group according to the digital parity method, 25 cases in each group.The control group was drilled at the thickest part of the skull hematoma, and the observation group was treated with Atorvastatin.The therapeutic effect, adverse reactions and recurrence, neurological function score and activity of daily life score of the two groups were compared.Results The total effective rate of the observation group was higher than that of the control group, the rates of adverse reactions and recurrence were lower than those of the control group, and the scores of neurological function and activities of daily life after treatment were lower than that of the control group,the differences were statistically significant (P＜0.05).Conclusion Atorvastatin is not only effective in the treatment of subacute subdural hematoma, but also can reduce the incidence of adverse reactions, reduce the recurrence rate, improve the neurological function, and improve the ability of daily life, which has significant clinical value.
黄安金. 探讨应用阿托伐他汀治疗亚急性硬膜下血肿的疗效及安全性[J]. 中国当代医药, 2020, 27(13): 37-39.
HUANG An-jin. Investigation on the efficacy and safety of Atorvastatin in the treatment of subacute subdural hematoma. 中国当代医药, 2020, 27(13): 37-39.
京公网安备 11010502046607号